News

Call to Action on Childhood TB

Notice from the Stop TB Partnership:

We are writing to encourage you to sign the Call to Action on Childhood TB.

The call was an outcome of an international meeting organized jointly by the European Centre for Disease Prevention and Control (ECDC) and the Stop TB Partnership’s Childhood TB Subgroup in March.

The meeting was attended by a wide range of participants, including researchers, paediatricians, community representatives, civil society organizations, and ECDC and WHO staff. The objectives of the meeting were to:

  • identify and highlight the gaps, challenges and needs in childhood TB control.
  • prepare the scientific rationale for the need for advocacy and to identify the key areas where more advocacy and targeted engagement with stakeholders are needed.
  • reach a consensus on how to advocate for childhood TB control.

There was strong consensus among participants on the urgent need to make the voice of children heard through concerted advocacy efforts. A detailed programme of the meeting, with all presentations, can be found at the ECDC website

The Call to Action is now available on the Stop TB Partnership website. Click here to sign.

Photo by John-Michael Maas

Learn more about childhood TB

Links to previous coverage of childhood TB by the WGND

WHO Releases Factsheet on Children and TB

MSF Podcast: Difficulties of Treating Children with TB

Interview with Dr. Anneke Hesseling: Part One, Part Two, and Part Three

TB R&D Weekly Update: Combined Isoniazid and Antiretroviral Therapy Protects HIV-infected Children

Interview with Mark Cotton: Part One and Part Two



More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...